Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Limitations Not yet FDA-approved (as of 2025)
Crucially, macro data does not sit in a silo
Since its launch, Ro has assisted more than 1.5 million patients and facilitated over 8 million digital health visits
Most are mild and manageable, but its important to know what to expect
A 2025 study evaluating patients with diabetes found that those using GLP-1 drugs may be at a lower risk of developing Alzheimers disease and other types of dementia
US$ 22.57
US$ 26.60
US$ 24.35
US$ 25.37
US$ 28.88
